Blue Pharmacies Public Ltd.

1 record, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• HEALTH C1 refused line

  Unauthorized nutrient content or health claim

  The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Blue Pharmacies Public Ltd.

Is Blue Pharmacies Public Ltd. on an FDA import alert?

No listing for Blue Pharmacies Public Ltd. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Cyprus page.

Has FDA refused shipments from Blue Pharmacies Public Ltd.?

Yes. FDA refused 1 shipment line from Blue Pharmacies Public Ltd. on May 7, 2019. The most recent, on May 7, 2019, was herbals & botanicals (not teas), n.e.c., charged as NCONTACT (no u.s. adverse event contact on supplement label).

Why did FDA refuse Blue Pharmacies Public Ltd.'s shipments?

The most frequent charges are HEALTH C (unauthorized nutrient content or health claim, 1 line) and NCONTACT (no u.s. adverse event contact on supplement label, 1 line).

What is Blue Pharmacies Public Ltd.'s FEI number?

Blue Pharmacies Public Ltd.'s FDA Establishment Identifier (FEI) is 3015295696.